M. Lispi

发表

Gene Expression and Apoptosis Levels in Cumulus Cells of Patients with Polymorphisms of FSHR and LHB Undergoing in Vitro Fertilization Program

P. Piomboni, G. Ruvolo, D. Santi, 2017, Cellular Physiology and Biochemistry.

Reduced FSH and LH action: implications for medically assisted reproduction

N. Raine-Fenning, M. Simoni, A. Hanyaloglu, 2021, Human reproduction.

Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.

A. Allignol, T. D Hooghe, C. Roeder, 2022, Best practice & research. Clinical obstetrics & gynaecology.

LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling

M. Simoni, A. La Marca, D. Tagliasacchi, 2012, PloS one.

Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival

M. Simoni, A. Hanyaloglu, F. Fanelli, 2020, bioRxiv.

B. Mol, C. Venetis, T. D’Hooghe, 2021, Reproductive Biology and Endocrinology.

Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals.

G. Scotland, J. Luyten, M. Connolly, 2022, Best practice & research. Clinical obstetrics & gynaecology.

LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse

M. De Felici, F. Klinger, S. Longobardi, 2016, Cell Death and Differentiation.

Comparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin alpha).

D. Mendola, M. Mancinelli, M. Lispi, 2006, Reproductive biomedicine online.

Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival

M. Simoni, A. Hanyaloglu, F. Fanelli, 2020, iScience.

Heterogeneity of commercial recombinant human growth hormone (r-hGH) preparations containing a thioether variant.

M. Rossi, F. Chiarelli, D. Mendola, 2009, Journal of pharmaceutical sciences.

Sex hormone levels in the brain of d-aspartate-treated rats.

M. M. Di Fiore, A. D’Aniello, M. Venditti, 2018, Comptes rendus biologies.

Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions

A. Ulloa-Aguirre, A. Palmese, N. Sepe, 2022, International journal of molecular sciences.

Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models.

S. Sunkara, S. Esteves, P. Drakopoulos, 2022, Best practice & research. Clinical obstetrics & gynaecology.

Recombinant FSH Improves Sperm DNA Damage in Male Infertility: A Phase II Clinical Trial

V. de Leo, P. Piomboni, G. Ruvolo, 2018, Front. Endocrinol..

Testosterone Serum Levels Are Related to Sperm DNA Fragmentation Index Reduction after FSH Administration in Males with Idiopathic Infertility

D. Santi, G. Spaggiari, M. Simoni, 2022, Biomedicines.

Analytical identification of additional impurities in urinary-derived gonadotrophins.

A. van Dorsselaer, M. Mancinelli, M. Lispi, 2009, Reproductive biomedicine online.

Exploring the human chorionic gonadotropin induced steroid secretion profile of mouse Leydig tumor cell line 1 by a 20 steroid LC-MS/MS panel

U. Pagotto, D. Santi, M. Simoni, 2023, The Journal of Steroid Biochemistry and Molecular Biology.

Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells

A. Cimini, V. Cela, E. Benedetti, 2016, Journal of cellular physiology.

Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation.

V. Korsak, M. Anshina, M. Lispi, 2022, Best practice & research. Clinical obstetrics & gynaecology.

APOPTOSIS RATE IN CUMULUS CELLS AS POSSIBLE MOLECULAR BIOMARKERFOR OOCYTE COMPETENCE.

G. Ruvolo, C. Martino, R. Chiarelli, 2017 .

POSTER VIEWING SESSION - FEMALE (IN) FERTILITY

S. Campbell, H. Steiner, B. Mol, 2011 .

LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro.

S. Tagliavini, T. Trenti, M. Simoni, 2022, Human reproduction.

Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain

S. Gizzo, M. Ferrando, M. Lispi, 2019, Journal of medical economics.

A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain

S. Gizzo, M. Ferrando, M. Lispi, 2018, Journal of medical economics.

Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose'.

S. Marque, C. Helwig, M. Lispi, 2023, Journal of Gynecology Obstetrics and Human Reproduction.

Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.

A. Allignol, T. D Hooghe, C. Roeder, 2022, Best Practice & Research: Clinical Obstetrics & Gynaecology.

Biological Assay to Determine Gonadotropin Potency: From In Vivo to In Vitro Sustainable Method

A. Palmese, Flavio Peroglio, M. Lispi, 2023, International journal of molecular sciences.

Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy?

G. Bousfield, P. Humaidan, A. Ulloa-Aguirre, 2023, International journal of molecular sciences.

Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study.

B. Hayward, A. Bielfeld, D. Chuderland, 2023, Best practice & research. Clinical obstetrics & gynaecology.